Tianyin Pharmaceutical Co., Inc. (TPI)

[surf1944]

3:27PM Tianyin Pharma signs Macrolide API International sales and marketing agreement ; forecasts $30 mln domestic Azithromycin API revenue in China for first year of operation (TPI) 1.50 +0.02 : Co signed sales and marketing agreement with RELATIONS International. The co forecasts $30 million domestic Azithromycin API revenue in China for the first year of operation from its Jiangchuan macrolide facility that has an annual manufacturing capacity of 250 tons. The international sales revenue from macrolide API is expected to contribute additional revenue for TPI.